A fair political calculation to make, but it's unlikely to be that easy

April 26, 2023 Latest News BioPharma Comment

This is a preview of subscriber content

Subscribe now to continue reading.

Health minister Mark Butler must already understand that this fight over increased dispensed quantities will not be like staring down companies on the recent catch-up statutory price reductions. …

Subscribe now to continue reading.

Latest Video

An exceptional outcome that must not become an exception
October 18, 2025 - Latest News
Trump announces third MFN deal with a focus on fertility drug costs and expanding IVF access
October 18, 2025 - Latest News
BMS says September outcome could set a new policy benchmark for access
October 18, 2025 - Latest News
New combination therapy sets landmark survival benchmark in bladder cancer treatment
October 19, 2025 - Latest News
Merck expands commitment to first nations STEM leadership with new scholarships and partnerships
October 19, 2025 - Latest News

A fair political calculation to make, but it's unlikely to be that easy

This is a preview of subscriber content

Latest Video

Most Read

An exceptional outcome that must not become an exception

Trump announces third MFN deal with a focus on fertility drug costs and expanding IVF access

BMS says September outcome could set a new policy benchmark for access

New combination therapy sets landmark survival benchmark in bladder cancer treatment

Merck expands commitment to first nations STEM leadership with new scholarships and partnerships

New Stories

Endometriosis diagnoses in Australian GP clinics Nearly double over a decade

'Patient-centric partnerships will unlock brighter and more equitable outcomes for all'

Vaccine confidence slips as Australians grow more concerned about access to healthcare

NZ's Pharmac proposes new rules to manage 'Options for Investment' list - make it shorter

Monash scientists crack genetic ‘code’ behind RNA splicing, opening door to to new therapies

Radiopharm secures funding to accelerate radiopharmaceutical pipeline as data show strong momentum

Neuren secures FDA 'Fast Track Designation' for NNZ-2591 in Phelan-McDermid Syndrome

Sign In

A fair political calculation to make, but it's unlikely to be that easy

This is a preview of subscriber content

Latest Video

Most Read

An exceptional outcome that must not become an exception

Trump announces third MFN deal with a focus on fertility drug costs and expanding IVF access

BMS says September outcome could set a new policy benchmark for access

New combination therapy sets landmark survival benchmark in bladder cancer treatment

Merck expands commitment to first nations STEM leadership with new scholarships and partnerships

Follow Us

New Stories

Endometriosis diagnoses in Australian GP clinics Nearly double over a decade

'Patient-centric partnerships will unlock brighter and more equitable outcomes for all'

Vaccine confidence slips as Australians grow more concerned about access to healthcare

NZ's Pharmac proposes new rules to manage 'Options for Investment' list - make it shorter

Monash scientists crack genetic ‘code’ behind RNA splicing, opening door to to new therapies

Radiopharm secures funding to accelerate radiopharmaceutical pipeline as data show strong momentum

Neuren secures FDA 'Fast Track Designation' for NNZ-2591 in Phelan-McDermid Syndrome